Investing.com - Financial Markets Worldwide
Get 40% Off
Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Zepp Health Corp (ZEPP)

NYSE
Currency in USD
Disclaimer
0.8849
+0.0449(+5.35%)
Closed
After Hours
0.8530-0.0319(-3.6049%)

ZEPP Comments

Buy for 5.5
I like amazefit
Time to buy Zepp.
Full of good news today guys: https://finance.yahoo.com/news/zepp-health-introduces-next-gen-114100550.html
Jó, hogy olcsón bevásároltam ebből kb. 1,5 hónapja :)
igen, szerintem is jól tetted ;)
https://huami.cdn.bcebos.com/uploads/ir-files/611e3a958497c.pdf
Finally, things start to make sense, PAI Healh is owned by Zepp health: https://www.globenewswire.com/news-release/2021/07/13/2261766/0/en/PAI-Health-partners-with-Zurich-Brazil-with-the-goal-of-improving-health-outcomes.html
https://finance.yahoo.com/news/amazfits-upcoming-product-redefine-tws-130000006.html
short sqeeze here too?
looks bad
yes, quite ugly, I beleive in them and their projections so I will hold more...
I will buy back some shares once I see it clearly.
Yeah, good idea! Let's see, I already did my bet, so I will see if I am going to be a bag holder or very nicely rewarded for my patience :D However I see good signs, they grow a lot the sales of Zepp brand and I cannot forget the 2 other business opportunities to build their ecosystem as a heathcare company and health insurance business. They "only" have to execute, fingers crossed, good luck for you and a lot of patience ;)
Zepp Health Corp. (NYSE: ZEPP) today reported revenue of RMB1.1 billion (US$175.1 million); GAAP diluted net loss per share of RMB0.16 (US$0.02); and GAAP diluted net loss per ADS of RMB0.64 (US$0.10) for the first quarter ended March 31, 2021. Each ADS represents four (4) Class A ordinary shares.
...but not so bad after all: the guidance for next quarter is good and the revenue from self-branded product is expanding. Let's see if this massive hiring of salesmen and researchers will translate in real growth
...but not so bad after all: the guidance for next quarter is good and the revenue from self-branded product is expanding. Let's see if this massive hiring of salesmen and researchers will translate in real growth
Doesn't look good the net loss... a bit painful after all this downtrend and not so good news even from Q4 and now in Q1 however the guidence seems ambitious for Q2."second quarter of 2021, the management of the Company currently expects:-  Net revenues to be between RMB1.7 billion and RMB1.8 billion, compared with RMB1.14 billion in the second quarter of 2020.""Our strong guidance for the second quarter reflects our expectation of continued strength of our Amazfit and Zepp brands, as well as new Xiaomi shipments. While we continue to manage expenses, the ongoing pandemic has brought challenges to our expense coverage, and we keep investing in the growth of our business. We expect to return to GAAP profitability in Q2 this year."
Maybe someone is here beside me: first quarter of 2021 unaudited financial results before the market open on Thursday, May 13, 2021.
This thing looks like it's gone bankrupt. I don't know what to expect of the earnings.
to be honest me neither but it's extremely undervalued. Hopefully this year Zepp will have some good news, they start to execute on the other 2 pillars and move to the healthcare business beside changin the name :D being Xiaomi whatch manufacturer is nice but the future can be brighter but let's see how they execute. I am very curiois about the insurance business opportunity too, there can be many growth optionssss I just want to see some already :D
now we know this is not undervalued at all. It can drop another 50% and still wouldn't be undervalued
hi guys, do you think we hit the bottom with 10.30? :D srems like a strong support level
well, at the end I just bought more. It seems a a very attractive price!!
Theoretical bottom is the free cash amount on a share. 5 usd.
If you simply compare market cap and revenue, you will realize how undervalued is this company, and everythingbelow $15 is a steal. The main problems are Covid restrictions and lack of good advertising. But better days are ahead of us
exactly, just a matter of time to double the market cap but some catalyst is needed, some food news.. like they enter to the health insurance business for real 🚀🚀🚀
report of 2020 is out: https://www.huami.com/investor/news
https://www.wareable.com/smartwatches/amazfit-to-launch-ecg-and-blood-pressure-as-zepp-health-gets-serious-8345
https://www.wareable.com/smartwatches/amazfit-to-launch-ecg-and-blood-pressure-as-zepp-health-gets-serious-8345
I love this comoany, I will load up before the earnings as much as I can, we are still below 15 USD :D let'S fly high once people reailze the potential
next Monday ZEPP earning Hope for a spike up
so what's up guys, anyone buying this stock at all? Or I am the only one? :D
i bought 400$
HMI --> ZEPP Health big data, AI, biotech, personal health, hightech wearables, etc.
can you find somewhere the price for Huami? Even my bank doesn't find it... ****
it is now zepp health
IN before $100! Huami (Zepp Health Corp.) is going to be HUGE.
this will bounce back to 20
Earnings are not good..
Earnings were better than last quarter but not as expected. They are doing tremendous in sales compare to there peers. You will surely see it double from here in few months
nice!
Buy buy buy
Okay done
Earnings ??
hey ,,just took a position ✌️🍀👽
Just another week and then this will fly like a......
Huami extends its partnership with xaomi for another 3 years. This is going to rocket
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.